Please login to the form below

Not currently logged in

Healthware Group appoints Yannick Valenti as digital strategy and customer engagement director

Prior to Healthware, Valenti spent three years at Ogilvy Health as digital strategy director

Healthware Group has appointed Yannick Valenti (pictured above) as digital strategy and customer engagement director in the UK.

Valenti joins Healthware from Ogilvy Health, where he spent three years working as digital strategy director. Prior to that, he was European general manager for digital advertising company SRAX and also previously served as head of digital strategies at Sudler International.

He has worked with a number of high profile pharma clients, including Roche, Pfizer, Bayer and Novartis across a range of therapeutics areas.

“I am delighted to welcome Yannick to the ever-expanding Healthware International team in UK," said Paul Tunnah, chief content officer and managing director, UK at Healthware.

"His healthcare marketing and digital tech strategy experience are an important addition to our company, and the wider Healthware Group, as we continue to drive excellence in digital transformation," he added.

Commenting on his appointment, Valenti said: “I am very happy to become part of the Healthware family, a group committed to the latest advancements in digital health and innovation, and I look forward to combining rigorous digital strategies and customer engagement expertise to help pharmaceutical brands move toward the future of health.”

Article by
Lucy Parsons

29th April 2021

From: PME


COVID-19 Updates and Daily News

Featured jobs


Add my company

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >300 healthcare communications professionals,...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...